FOLD- Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Activity
Buys and sells only
Transactions
10 filings · page 8
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Crowley John F67 | Executive Chairman | Sell | 6,044 | $11.22 | $67,787.09 | -0.6% | +9.1% | +1.0% | |
| Mar 17, 2023 | Raab Michael56 | Director | Sale+OE | 4,408 | $11.33 | $49,942.64 | -6.8% | +15.3% | +2.1% | |
| Mar 15, 2023 | Crowley John F67 | Executive Chairman | Sell | 6,044 | $11.34 | $68,547.42 | -0.6% | +13.8% | +1.0% | |
| Mar 1, 2023 | Campbell Bradley L66 | President &CEO | Sale+OE | 20,000 | $13.24 | $264,861.18 | -1.2% | -17.4% | -5.3% | |
| Mar 1, 2023 | Crowley John F67 | Executive Chairman | Sell | 6,044 | $13.42 | $81,093.02 | -0.3% | -17.4% | -5.3% | |
| Feb 15, 2023 | Crowley John F67 | Executive Chairman | Sell | 6,044 | $12.94 | $78,217.22 | -0.6% | -18.2% | +6.8% | |
| Feb 1, 2023 | Crowley John F67 | Executive Chairman | Sale+OE | 147,316 | $13.11 | $1,931,342.22 | -12.8% | -12.2% | -3.7% | |
| Feb 1, 2023 | Campbell Bradley L66 | President &CEO | Sale+OE | 20,000 | $12.98 | $259,508.00 | -2.3% | -12.2% | -3.7% | |
| Jan 24, 2023 | Rosenberg Ellen65 | Chief Legal Officer | Sell | 31,839 | $13.32 | $424,006.33 | -8.7% | -14.2% | -6.1% | |
| Jan 18, 2023 | Clark David Michael64 | Chief People Officer | Sell | 7,382 | $13.50 | $99,657.00 | -3.0% | -9.2% | -5.2% |